Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 实验方法 > 免疫技术

免疫技术

Immunoaffinity Methods for Purification of Complement Components and Regulators

2025-07-09 免疫技术 加入收藏
Immunoaffinity protocols offer a rapid, efficient, and simple way of obtaining a

Immunoaffinity protocols offer a rapid, efficient, and simple way of obtaining a protein of interest. Almost all of the complement components, receptors, and regulators have been successfully isolated by immunoaffinity protocols. The use of these methods is limited only by the availability of suitable antibodies in sufficient quantities (1 –6 ). Immunoaffinity methods are compatible with most detergents used in the solubilization of membrane proteins and are thus well suited to the purification of membrane regulators of complement and complement receptors (3 ,7 ,8 ). Proteins isolated by immunoaffinity methods, particularly on monoclonal antibody solid phases, are usually of high purity and require either no downstream processing or simple “polishing” steps, such as gel filtration to remove aggregates. Elution of the bound protein from the antibody-solid phase is commonly achieved by subjecting the column to extremes of pH to disrupt antibody-antigen interaction. Some complement proteins are labile at these pH extremes and methods must be modified accordingly (Table 1 ). Here, I will describe the steps followed in establishing an immunoaffinity protocol for a complement protein. These differ little from those used for any other target protein. Example protocols will be provided for a serum complement protein and a membrane bound complement regulator. Table 1  Modifications of Basic Protocol for Specific Components

Componen

Problem

Solution

C l

Dissociates in absence of

Avoid chelating agents in serum/plasma,


divalent cations

use VBS instead of PBS, avoid chaotropes,



include protease inhibitor NPGB (1 mM).

C2/fB

Very prone to

Ensure all steps are performed at 4�C,


proteolysis/denaturation

include protease inhibitors in plasma and



buffers.

C3/C4

Very abundant in plasma,

Reduce the volume of plasma used-20 mL


column saturates

plasma should yield >10 mg C3!

fD

Very low concentrations

Consider alternative sources-urine from


in plasma

patients with renal pathology?

Properdin

Tendency to form

Minimize time of procedure keep at 4�C


aggregates

include protease inhibitors.

C8

Noncovalently associated

Avoid high salt wash (250 mM max), use


subunits (αγ/β)dissociate

solid phase which binds both subunits


in high salt

(mixed MAb).

C9

Labile at pH extremes

Elute in chaotropes (e.g., 2 MgCl2 ) or



minimize time of exposure by neutralizing



immediately.


文章底部广告位

文章评论

加载中~